Gene: ARL15
Official Full Name: ARF like GTPase 15provided by HGNC
Gene Summary: Predicted to enable GTP binding activity and GTPase activity. Located in extracellular exosome. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO19673 | ARL15 Knockout cell line (HeLa) | Human | ARL15 | 1:3~1:6 | Negative | Online Inquiry |
KO19674 | ARL15 Knockout cell line (HCT 116) | Human | ARL15 | 1:2~1:4 | Negative | Online Inquiry |
KO19675 | ARL15 Knockout cell line (HEK293) | Human | ARL15 | 1:3~1:6 | Negative | Online Inquiry |
KO19676 | ARL15 Knockout cell line (A549) | Human | ARL15 | 1:3~1:4 | Negative | Online Inquiry |
ARL15 Gene Knockout Cell Lines are genetically modified cell lines specifically engineered to lack the ARL15 gene, which encodes a member of the Arf-like protein family. These cell lines serve as robust tools for studying the biological roles and mechanisms mediated by the ARL15 gene in various physiological and pathological contexts. By facilitating the exploration of gene function, ARL15 Gene Knockout Cell Lines enable researchers to dissect cellular signaling pathways and metabolic processes influenced by this gene.
The primary function of these cell lines is to provide a controlled environment for researchers to investigate the effects of ARL15 deficiency on cellular behavior, including growth, differentiation, and response to stimuli. Mechanistically, ARL15 has been implicated in pathways associated with glucose homeostasis and insulin signaling; thus, these knockout cell lines are invaluable for probing metabolic disorders, including type 2 diabetes and obesity. The unique phenotype exhibited by ARL15 knockout cells allows researchers to conduct comparative studies against wild-type counterparts, yielding insights into the gene's involvement in specific biological processes.
From a scientific perspective, ARL15 Gene Knockout Cell Lines hold significant applications in both basic and translational research. They are particularly beneficial for drug discovery programs focused on metabolic diseases, as well as for developing gene therapy strategies targeting disorders related to ARL15 dysregulation. Key advantages of these cell lines include their high reproducibility, ease of manipulation, and the potential for evaluating therapeutic interventions in a relevant cellular context.
Choosing ARL15 Gene Knockout Cell Lines over traditional models not only enhances scientific rigor but also delivers a powerful tool for researchers and clinicians striving for deeper understanding and innovative solutions in the realm of metabolic health. Our company, recognized for its commitment to providing high-quality biological products, ensures the integrity and reliability of these cell lines, supporting the advancement of research and clinical applications.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.